Dose-threshold for thyroid tumor-promoting effects of orally administered kojic acid in rats after initiation with N-bis(2-hydroxypropyl) nitrosamine.

DOI Web Site Web Site PubMed 被引用文献4件 参考文献51件
  • TAMURA Toru
    Division of Pathology, National Institute of Health Sciences
  • MITSUMORI Kunitoshi
    Division of Pathology, National Institute of Health Sciences Division of Veterinary Pathology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology
  • ONODERA Hiroshi
    Division of Pathology, National Institute of Health Sciences
  • FUJIMOTO Nariaki
    Department of Cancer Research, Research Institute of Radiation Biology and Medicine, Hiroshima University
  • YASUHARA Kazuo
    Division of Pathology, National Institute of Health Sciences
  • TAKEGAWA Kiyoshi
    Division of Pathology, National Institute of Health Sciences Safety Evaluation Drug Development Laboratories, Pharmaceutical Research Division, WelFide Corporation
  • TAKAGI Hisayoshi
    Division of Pathology, National Institute of Health Sciences
  • HIROSE Masao
    Division of Pathology, National Institute of Health Sciences

この論文をさがす

抄録

In order to evaluate the threshold dose of thyroid tumor-promoting effects of KA, male F344 rats were initiated with N-bis(2-hydroxypropyl) nitrosamine (DHPN; 2000 mg/kg body wt., single s.c. injection) and, starting 1 week later, received pulverized basal diet containing 0%, 0.002%, 0.008%, 0.03%, 0.125%, 0.5% or 2%KA for 20 weeks. Five rats each in the 0%, 0.125%, 0.5% and 2%KA groups were sacrificed at week 12, and 10 rats each in all groups at week 20. As an additional experiment, three groups without DHPN initiation received basal diet, a diet containing 0.5% or 2%KA for 20 weeks. The serum T4 levels were significantly decreased in the DHPN-initiated groups given 0.125%KA or more at week 12. No significant decreases in serum T3 levels were observed in the groups treated with DHPN+KA and a significant increase was evident in the 2%KA-alone group at week 20. Some rats in the DHPN+2%KA group at weeks 12 and 20 and the 2%KA-alone group at week 20 showed pronounced elevation of serum TSH. Thyroid weights were significantly increased in the DHPN-initiated groups receiving 0.5% and 2%KA at weeks 12 and 20 and in the 2%KA-alone group at week 20. Histopathologically, the incidences of focal thyroid follicular cell hyperplasias in the DHPN-initiated groups treated with 0.125%, 0.5% and 2%KA at week 20 were 5/10, 10/10 and 8/8 rats, respectively. At week 20, adenomas were observed in 7/10 rats in the DHPN+0.5%KA group and 8/8 rats in the DHPN+2%KA group, and carcinomas were observed in 6/8 rats in the DHPN+2%KA group. In the groups without DHPN initiation, only focal follicular cell hyperplasia was observed in 1/9 rats in the 2%KA-alone group. These results suggest that the no-observed-adverse effect for the thyroid tumor-promoting effect of KA is 0.03% (15.5 mg/kg/day) under the present experimental conditions, and that KA possesses weak tumorigenic activity in rats due to continuous serum TSH stimulation by a non-genotoxic mechanism.

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (51)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ